TY 2021 Form 990 Schedule O

efile Public Visual Render ObjectId: 202223199349320957 - Submission: 2022-11-15 TIN: 46-0902111

SCHEDULE O
(Form 990)

Department of the Treasury
Internal Revenue Service

Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or 990-EZ or to provide any additional information.
MediumBullet

Attach to Form 990 or 990-EZ.
MediumBullet

Go to www.irs.gov/Form990 for the latest information.

OMB No. 1545-0047

2021

Open to Public
Inspection

Name of the organization

RTOG FOUNDATION INC

Employer identification number

46-0902111

Return Reference	Explanation
FORM 990, PART III, LINE 1	2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH 3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION 4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOGF'S MEMBERSHIP IN NRG ONCOLOGY 5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOG'S RESEARCH MISSION 6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOGF IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES 7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOG RESEARCH ENTERPRISE.
FORM 990, PART VI, SECTION A, LINE 8B	NO BOARD COMMITTEES HAVE BEEN FORMED AS OF THIS TIME.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE RETURN WILL THEN BE REVIEWED BY THE SECRETARY-TREASURER AND APPROVED. THE RETURN WILL THEN BE MADE AVAILABLE FOR ALL DIRECTORS PRIOR TO ITS FILING.
FORM 990, PART VI, SECTION B, LINE 12C	THE CONFLICT OF INTEREST POLICY APPLIES TO BOARD MEMBERS, OFFICERS, COMMITTEE MEMBERS, STAFF, VOLUNTEERS, CLINICAL INVESTIGATORS AND ALL OTHERS REPRESENTING OR ACTING ON BEHALF OF RTOG. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST. THE DISCLOSURE IS REVIEWED BY THE RTOG ADMINISTRATOR WITH GUIDANCE FROM RTOG LEGAL COUNSEL. ANY IDENTIFIED FINANCIAL CONFLICT OF INTEREST (FCOI) WILL BE REVIEWED WITH THE AFFECTED INVESTIGATOR AND, IF APPLICABLE, REPORTED TO NIH WITHIN 60 DAYS OF DISCOVERY AND ACTIONS TO MANAGE, REDUCE OR ELIMINATE THE FCOI WILL BE TAKEN BY THE ADMINISTRATOR OF THE RESEARCH ACTIVITY INVOLVED AND INCLUDED IN THE REPORT TO NATIONAL INSTITUTES OF HEALTH (NIH). MANAGEMENT OF AN IDENTIFIED FCOI WILL INCLUDE THE DEVELOPMENT AND IMPLEMENTATION OF A MANAGEMENT PLAN AND, IF NECESSARY, A RETROSPECTIVE REVIEW AND MITIGATION REPORT.
FORM 990, PART VI, SECTION C, LINE 19	THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.
FORM 990, PART XI, LINE 9:	ADJUSTMENT TO FINANCIAL POSITION FOR ACR 1,585,000. INVESTMENT IN NRG 700,000.

Return Reference

Explanation

FORM 990, PART III, LINE 1

2) EVALUATE NEW FORMS OF RADIOTHERAPY DELIVERY AND TEST NEW SYSTEMIC AND TARGETED THERAPIES IN CONJUNCTION WITH RADIOTHERAPY IN THE CONTEXT OF CLINICAL RESEARCH 3) PARTICIPATE AS ONE OF THREE MEMBER ORGANIZATIONS IN THE ACTIVITIES OF NRG ONCOLOGY FOUNDATION 4) DEVELOP AND CONDUCT PRACTICE-CHANGING CLINICAL TRIALS FOR THE NCI NATIONAL CLINICAL TRIAL NETWORK (NCTN) THROUGH RTOGF'S MEMBERSHIP IN NRG ONCOLOGY 5) DEVELOP AND CONDUCT INDUSTRY-SUPPORTED CLINICAL TRIALS THAT ARE IMPORTANT TO RTOG'S RESEARCH MISSION 6) PROVIDE FUNDING FOR BASIC, CLINICAL, AND TRANSLATIONAL INVESTIGATORS TO COLLABORATE WITH RTOGF IN THE DEVELOPMENT OF BOTH BIOLOGIC AND BIOPHYSICAL TARGETED THERAPIES 7) SUPPORT YOUNG INVESTIGATORS FROM MANY DISCIPLINES WITHIN THE RTOG RESEARCH ENTERPRISE.

FORM 990, PART VI, SECTION A, LINE 8B

NO BOARD COMMITTEES HAVE BEEN FORMED AS OF THIS TIME.

FORM 990, PART VI, SECTION B, LINE 11B

THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE RETURN WILL THEN BE REVIEWED BY THE SECRETARY-TREASURER AND APPROVED. THE RETURN WILL THEN BE MADE AVAILABLE FOR ALL DIRECTORS PRIOR TO ITS FILING.

FORM 990, PART VI, SECTION B, LINE 12C

THE CONFLICT OF INTEREST POLICY APPLIES TO BOARD MEMBERS, OFFICERS, COMMITTEE MEMBERS, STAFF, VOLUNTEERS, CLINICAL INVESTIGATORS AND ALL OTHERS REPRESENTING OR ACTING ON BEHALF OF RTOG. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST. THE DISCLOSURE IS REVIEWED BY THE RTOG ADMINISTRATOR WITH GUIDANCE FROM RTOG LEGAL COUNSEL. ANY IDENTIFIED FINANCIAL CONFLICT OF INTEREST (FCOI) WILL BE REVIEWED WITH THE AFFECTED INVESTIGATOR AND, IF APPLICABLE, REPORTED TO NIH WITHIN 60 DAYS OF DISCOVERY AND ACTIONS TO MANAGE, REDUCE OR ELIMINATE THE FCOI WILL BE TAKEN BY THE ADMINISTRATOR OF THE RESEARCH ACTIVITY INVOLVED AND INCLUDED IN THE REPORT TO NATIONAL INSTITUTES OF HEALTH (NIH). MANAGEMENT OF AN IDENTIFIED FCOI WILL INCLUDE THE DEVELOPMENT AND IMPLEMENTATION OF A MANAGEMENT PLAN AND, IF NECESSARY, A RETROSPECTIVE REVIEW AND MITIGATION REPORT.

FORM 990, PART VI, SECTION C, LINE 19

THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST.

FORM 990, PART XI, LINE 9:

ADJUSTMENT TO FINANCIAL POSITION FOR ACR 1,585,000. INVESTMENT IN NRG 700,000.

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.

Cat. No. 51056K

Schedule O (Form 990) 2021

Software ID:
Software Version: